Terms of Use.
Last updated · June 14, 2026
Acceptance of these terms
By accessing or using the website at https://culgenesis.com (the "Site"), you agree to these Terms of Use. If you do not agree, please do not use the Site.
About the content on this Site
This Site presents information about CULGenesis, a Cornell-origin biotech platform developing patented small-molecule modulation of CUL4-regulated nucleotide excision repair. The Site is intended for informational purposes only and is directed primarily at qualified investors, scientific collaborators, and prospective strategic partners.
Content on this Site may include forward-looking statements about platform potential, development milestones, and intended applications. Such statements reflect current hypotheses and are subject to material risks, uncertainties, and change. They should not be interpreted as guarantees of future performance or as commitments regarding product availability, regulatory status, or therapeutic claims.
Not medical or investment advice
Nothing on this Site constitutes:
- Medical advice. The Site does not provide diagnosis, treatment recommendations, or guidance regarding any medical condition. CULGenesis is developing platform technology; no product described here is currently available for therapeutic use unless specifically and explicitly stated.
- Investment advice or solicitation. Any references to fundraising rounds, valuations, or financial milestones are informational only. They do not constitute an offer to sell or a solicitation to buy any securities. Securities may only be offered pursuant to applicable exemptions and definitive transaction documents.
- A regulatory determination. References to MoCRA or other regulatory frameworks describe the framework within which CULGenesis is developing its initial program. They do not represent regulatory clearance, approval, or any specific regulatory status.
Intellectual property
All content on this Site — including text, graphics, the CULGenesis "C" mark, SVG diagrams, and the underlying code — is owned by CULGenesis or its licensors. You may not reproduce, distribute, or create derivative works from this content without prior written permission, except for fair-use excerpts in journalism, academic citation, or due-diligence contexts.
References to peer-reviewed literature (Premi et al. 2015; López-Otín et al. 2013/2023; and others) are made for educational purposes; copyright in those works remains with the original publishers.
Forward-looking statements & uncertainty
Statements regarding intended product launches, platform extensions to other epithelial interfaces, scientific hypotheses, and development timelines are forward-looking. They are based on current information and reasonable assumptions, but actual outcomes may differ materially. Risks include but are not limited to: scientific results that fail to support the hypothesis; regulatory decisions; funding availability; intellectual-property challenges; manufacturing, formulation, or supply-chain issues; and broader market or macro factors.
External links
The Site may contain links to third-party resources, including peer-reviewed journals and partner organizations. CULGenesis does not control those resources and is not responsible for their content or practices.
Changes to these terms
CULGenesis may revise these Terms of Use as the business evolves. The "Last updated" date at the top reflects the most recent revision. Continued use of the Site following changes constitutes acceptance.
Contact
Questions about these Terms: inquiry@culgenesis.com